JP Stock MarketDetailed Quotes

4528 Ono Pharmaceutical

Watchlist
  • 1735.5
  • +19.0+1.11%
20min DelayMarket Closed Mar 11 15:30 JST
865.48BMarket Cap6.51P/E (Static)

Ono Pharmaceutical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
Total revenue
2.31%134.22B
-1.95%117.68B
12.41%502.67B
4.25%112.77B
7.25%131.19B
26.11%138.7B
12.46%120.02B
23.75%447.19B
20.28%108.17B
25.64%122.32B
Cost of revenue
49.32%45.84B
-1.66%29.67B
15.50%127.13B
20.51%31.66B
2.07%30.7B
29.20%34.59B
12.01%30.17B
17.70%110.06B
14.85%26.28B
19.98%30.08B
Gross profit
-12.05%88.39B
-2.05%88B
11.40%375.55B
-0.96%81.11B
8.94%100.49B
25.12%104.1B
12.61%89.84B
25.86%337.12B
22.13%81.89B
27.61%92.24B
Operating expense
38.96%73.51B
18.18%57.32B
10.48%215.61B
5.24%65.8B
5.96%52.9B
17.81%48.42B
16.51%48.5B
18.53%195.16B
35.83%62.52B
3.39%49.93B
Selling and administrative expenses
37.46%35.32B
18.75%27.89B
12.05%100.27B
15.58%26.98B
10.73%25.69B
13.68%24.12B
8.09%23.48B
16.13%89.49B
19.27%23.34B
16.99%23.2B
-General and administrative expense
37.46%35.32B
18.75%27.89B
12.05%100.27B
15.58%26.98B
10.73%25.69B
13.68%24.12B
8.09%23.48B
16.13%89.49B
19.27%23.34B
16.99%23.2B
Research and development costs
41.05%38.27B
17.41%28.86B
17.65%112.17B
21.49%35.68B
2.98%27.13B
22.58%24.78B
26.61%24.58B
25.65%95.34B
11.19%29.37B
55.78%26.35B
Other operating expenses
-20.00%132M
10.13%609M
-60.75%4.34B
-66.72%3.34B
-62.33%165M
2,308.33%289M
-6.27%553M
-12.86%11.07B
3,531.88%10.02B
-96.23%438M
Total other operating income
140.00%204M
-68.64%37M
60.22%1.18B
-8.80%197M
39.34%85M
121.08%776M
11.32%118M
-25.10%734M
-8.09%216M
-19.74%61M
Operating profit
-68.74%14.88B
-25.78%30.69B
12.66%159.94B
-20.97%15.31B
12.46%47.59B
32.25%55.69B
8.35%41.35B
37.57%141.96B
-7.87%19.37B
76.37%42.32B
Net non-operating interest income (expenses)
522.17%2.53B
153.88%2.62B
142.68%3.8B
616.36%1.14B
-60.96%406M
1,013.43%1.22B
17.27%1.03B
-14.76%1.57B
36.78%-220M
-7.39%1.04B
Non-operating interest income
23.21%1.86B
111.70%2.7B
62.51%4.03B
1,214.49%907M
27.59%1.51B
1,813.85%1.24B
9.84%1.27B
-8.56%2.48B
-60.12%69M
5.52%1.19B
Non-operating interest expense
-159.95%-663M
-68.88%75M
-74.92%229M
-179.24%-229M
662.76%1.11B
-89.95%20M
-13.62%241M
4.46%913M
-44.53%289M
--145M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
1M
0
-75.00%1M
-3M
0
100.00%6M
-2M
166.67%4M
0
1M
Special income (charges)
Other non-operating income (expenses)
Income before tax
-63.75%17.4B
-21.40%33.31B
14.07%163.73B
-14.15%16.44B
10.69%48B
35.59%56.92B
8.55%42.38B
36.66%143.53B
-7.37%19.15B
72.63%43.36B
Income tax
-78.88%2.51B
-19.75%8.47B
16.57%35.69B
-147.78%-988M
19.36%11.91B
56.84%14.22B
11.01%10.56B
25.80%30.62B
-55.62%2.07B
47.06%9.98B
Net income
-58.75%14.89B
-21.95%24.84B
13.40%128.04B
2.01%17.43B
8.10%36.09B
29.74%42.7B
7.76%31.82B
39.94%112.91B
6.69%17.09B
82.08%33.39B
Net income continuous operations
-58.75%14.89B
-21.94%24.84B
13.40%128.04B
2.02%17.43B
8.10%36.09B
29.74%42.7B
7.76%31.82B
39.94%112.91B
6.67%17.09B
82.08%33.39B
Noncontrolling interests
-275.68%-65M
42M
-67.37%62M
-122.22%-4M
-45.59%37M
-44.23%29M
0
14.46%190M
-84.75%18M
1,260.00%68M
Net income attributable to the company
-58.53%14.95B
-22.08%24.79B
13.53%127.98B
2.14%17.43B
8.21%36.05B
29.86%42.67B
7.94%31.82B
40.00%112.72B
7.35%17.07B
81.76%33.32B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-58.53%14.95B
-22.08%24.79B
13.53%127.98B
2.14%17.43B
8.21%36.05B
29.86%42.67B
7.94%31.82B
40.00%112.72B
7.35%17.07B
81.76%33.32B
Gross dividend payment
Basic earnings per share
-57.99%31.83
-18.98%52.79
15.49%266.61
7.38%37.53
11.05%75.77
31.03%88.18
7.93%65.16
42.33%230.85
7.27%34.95
85.26%68.23
Diluted earnings per share
-58.01%31.81
-19.03%52.75
15.50%266.57
7.45%37.51
11.05%75.76
31.03%88.18
7.94%65.15
42.32%230.79
7.18%34.91
85.28%68.22
Dividend per share
0
0
14.29%80
8.11%40
0
21.21%40
0
25.00%70
32.14%37
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Dec 31, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022
Total revenue 2.31%134.22B-1.95%117.68B12.41%502.67B4.25%112.77B7.25%131.19B26.11%138.7B12.46%120.02B23.75%447.19B20.28%108.17B25.64%122.32B
Cost of revenue 49.32%45.84B-1.66%29.67B15.50%127.13B20.51%31.66B2.07%30.7B29.20%34.59B12.01%30.17B17.70%110.06B14.85%26.28B19.98%30.08B
Gross profit -12.05%88.39B-2.05%88B11.40%375.55B-0.96%81.11B8.94%100.49B25.12%104.1B12.61%89.84B25.86%337.12B22.13%81.89B27.61%92.24B
Operating expense 38.96%73.51B18.18%57.32B10.48%215.61B5.24%65.8B5.96%52.9B17.81%48.42B16.51%48.5B18.53%195.16B35.83%62.52B3.39%49.93B
Selling and administrative expenses 37.46%35.32B18.75%27.89B12.05%100.27B15.58%26.98B10.73%25.69B13.68%24.12B8.09%23.48B16.13%89.49B19.27%23.34B16.99%23.2B
-General and administrative expense 37.46%35.32B18.75%27.89B12.05%100.27B15.58%26.98B10.73%25.69B13.68%24.12B8.09%23.48B16.13%89.49B19.27%23.34B16.99%23.2B
Research and development costs 41.05%38.27B17.41%28.86B17.65%112.17B21.49%35.68B2.98%27.13B22.58%24.78B26.61%24.58B25.65%95.34B11.19%29.37B55.78%26.35B
Other operating expenses -20.00%132M10.13%609M-60.75%4.34B-66.72%3.34B-62.33%165M2,308.33%289M-6.27%553M-12.86%11.07B3,531.88%10.02B-96.23%438M
Total other operating income 140.00%204M-68.64%37M60.22%1.18B-8.80%197M39.34%85M121.08%776M11.32%118M-25.10%734M-8.09%216M-19.74%61M
Operating profit -68.74%14.88B-25.78%30.69B12.66%159.94B-20.97%15.31B12.46%47.59B32.25%55.69B8.35%41.35B37.57%141.96B-7.87%19.37B76.37%42.32B
Net non-operating interest income (expenses) 522.17%2.53B153.88%2.62B142.68%3.8B616.36%1.14B-60.96%406M1,013.43%1.22B17.27%1.03B-14.76%1.57B36.78%-220M-7.39%1.04B
Non-operating interest income 23.21%1.86B111.70%2.7B62.51%4.03B1,214.49%907M27.59%1.51B1,813.85%1.24B9.84%1.27B-8.56%2.48B-60.12%69M5.52%1.19B
Non-operating interest expense -159.95%-663M-68.88%75M-74.92%229M-179.24%-229M662.76%1.11B-89.95%20M-13.62%241M4.46%913M-44.53%289M--145M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests 1M0-75.00%1M-3M0100.00%6M-2M166.67%4M01M
Special income (charges)
Other non-operating income (expenses)
Income before tax -63.75%17.4B-21.40%33.31B14.07%163.73B-14.15%16.44B10.69%48B35.59%56.92B8.55%42.38B36.66%143.53B-7.37%19.15B72.63%43.36B
Income tax -78.88%2.51B-19.75%8.47B16.57%35.69B-147.78%-988M19.36%11.91B56.84%14.22B11.01%10.56B25.80%30.62B-55.62%2.07B47.06%9.98B
Net income -58.75%14.89B-21.95%24.84B13.40%128.04B2.01%17.43B8.10%36.09B29.74%42.7B7.76%31.82B39.94%112.91B6.69%17.09B82.08%33.39B
Net income continuous operations -58.75%14.89B-21.94%24.84B13.40%128.04B2.02%17.43B8.10%36.09B29.74%42.7B7.76%31.82B39.94%112.91B6.67%17.09B82.08%33.39B
Noncontrolling interests -275.68%-65M42M-67.37%62M-122.22%-4M-45.59%37M-44.23%29M014.46%190M-84.75%18M1,260.00%68M
Net income attributable to the company -58.53%14.95B-22.08%24.79B13.53%127.98B2.14%17.43B8.21%36.05B29.86%42.67B7.94%31.82B40.00%112.72B7.35%17.07B81.76%33.32B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -58.53%14.95B-22.08%24.79B13.53%127.98B2.14%17.43B8.21%36.05B29.86%42.67B7.94%31.82B40.00%112.72B7.35%17.07B81.76%33.32B
Gross dividend payment
Basic earnings per share -57.99%31.83-18.98%52.7915.49%266.617.38%37.5311.05%75.7731.03%88.187.93%65.1642.33%230.857.27%34.9585.26%68.23
Diluted earnings per share -58.01%31.81-19.03%52.7515.50%266.577.45%37.5111.05%75.7631.03%88.187.94%65.1542.32%230.797.18%34.9185.28%68.22
Dividend per share 0014.29%808.11%40021.21%40025.00%7032.14%370
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP